| Title | Nanobiomedicine |
| Abbreviation | Nanobiomedicine |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Biomedical Engineering (Q3); Biotechnology (Q3) |
| h-index | 16 |
| Overall Rank/Ranking | 11175 |
| SCImago Journal Rank (SJR) | 0.482 |
| Impact Score | 2.00 |
| Publisher | SAGE Publications Ltd |
| Country | United Kingdom |
| ISSN | 18495435 |
| Best Quartile | Q3 |
| Coverage History | 2014-2022 |
Nanobiomedicine is a journal covering the technologies/fields/categories related to Biomedical Engineering (Q3); Biotechnology (Q3). It is published by SAGE Publications Ltd. The overall rank of Nanobiomedicine is 11175. According to SCImago Journal Rank (SJR), this journal is ranked 0.482. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 16. The best quartile for this journal is Q3.
The ISSN of Nanobiomedicine journal is 18495435. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Nanobiomedicine is cited by a total of 15 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Nanobiomedicine is 2.00, which is computed in 2024 as per its definition. Nanobiomedicine IF is decreased by a factor of 1.25 and approximate percentage change is -38.46% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Nanobiomedicine is 2.00. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.00 |
| 2022 | 3.25 |
| 2021 | 6.25 |
| 2020 | 4.40 |
| 2019 | 1.14 |
| 2018 | 1.72 |
| 2017 | 1.19 |
| 2016 | 1.35 |
| 2015 | 1.22 |
| 2014 | 0.00 |
Nanobiomedicine has an h-index of 16. It means 16 articles of this journal have more than 16 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Nanobiomedicine is 18495435. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Nanobiomedicine is 11175. According to SCImago Journal Rank (SJR), this journal is ranked 0.482. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.482 |
| 2022 | 0.880 |
| 2021 | 0.692 |
| 2020 | 0.561 |
| 2019 | 0.453 |
| 2018 | 0.533 |
| 2017 | 0.367 |
| 2016 | 0.256 |
| 2015 | 0.255 |
| 2014 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 11175 |
| 2022 | 5144 |
| 2021 | 6970 |
| 2020 | 8996 |
| 2019 | 10694 |
| 2018 | 9002 |
| 2017 | 11614 |
| 2016 | 15028 |
| 2015 | 14907 |
| 2014 | 32553 |
Nanobiomedicine is published by SAGE Publications Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2014-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Nanobiomedicine is Nanobiomedicine. This abbreviation ('Nanobiomedicine') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Biomedical Engineering (Q3); Biotechnology (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Nanobiomedicine latest impact IF is 2.00. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 6.25 (2021) and 0.00 (2014), respectively, in the last 10 years. Moreover, its average IS is 2.25 in the previous 10 years.
The Nanobiomedicine has an SJR (SCImago Journal Rank) of 0.482, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.880 in 2022 and the lowest being in 2014. Furthermore, the average SJR of the Nanobiomedicine over the previous 10-year period stands at 2.25.
The latest h-index of the Nanobiomedicine is 16.
The Nanobiomedicine is published by the SAGE Publications Ltd, with its country of publication being the United Kingdom.
The Nanobiomedicine is currently ranked 11175 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 5144 in 2022 and its lowest position of 32553 in 2014.
The standard ISO4 abbreviation for the Nanobiomedicine is Nanobiomedicine.
Nanobiomedicine is classified as a journal that the SAGE Publications Ltd publishes.
The Nanobiomedicine encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Nanobiomedicine is assigned the following International Standard Serial Numbers (ISSN): 18495435.
The best quartile for the Nanobiomedicine is Q3 (2023).
The Nanobiomedicine coverage history can be summarized as follows: 2014-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Discourse | journal | 6196 | Routledge | 65 | 2.36 |
| Modern Language Journal | journal | 1100 | Wiley-Blackwell | 112 | 3.93 |
| Socialism and Democracy | journal | 25103 | Taylor and Francis Ltd. | 18 | 0.12 |
| Journal of Sociolinguistics | journal | 3273 | Wiley-Blackwell Publishing Ltd | 64 | 1.85 |
| Expert Review of Clinical Pharmacology | journal | 4520 | Taylor and Francis Ltd. | 60 | 3.53 |
| Clinical Interventions in Aging | journal | 5314 | Dove Medical Press Ltd. | 104 | 3.55 |
| Journal of Medical Toxicology | journal | 7459 | Springer New York | 58 | 1.58 |
| English Literary Renaissance | journal | 25777 | University of Chicago Press | 20 | 0.36 |
| Physica Status Solidi - Rapid Research Letters | journal | 8109 | Wiley-VCH Verlag | 79 | 2.55 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 2.00 |
| 2022 | 3.25 |
| 2021 | 6.25 |
| 2020 | 4.40 |
| 2019 | 1.14 |
| 2018 | 1.72 |
| 2017 | 1.19 |
| 2016 | 1.35 |
| 2015 | 1.22 |
| 2014 | 0.00 |
